Found: 61
Select item for more details and to access through your institution.
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2865, doi. 10.1007/s00262-023-03432-4
- By:
- Publication type:
- Article
Predictors of impaired antibody response after SARS‐CoV‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 102, doi. 10.1002/ajh.26769
- By:
- Publication type:
- Article
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever.
- Published in:
- Mycoses, 2020, v. 63, n. 8, p. 794, doi. 10.1111/myc.13100
- By:
- Publication type:
- Article
Functional impairment of Tax-specific but not CMV-specific CTLs in a minor population of asymptomatic HTLV-1-carriers.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Successful treatment of a patient with cardiac lymphoma who presented with a complete atrioventricular block.
- Published in:
- American Journal of Hematology, 1998, v. 59, n. 2, p. 171, doi. 10.1002/(SICI)1096-8652(199810)59:2<171::AID-AJH12>3.0.CO;2-C
- By:
- Publication type:
- Article
Soluble fas in the serum of patients with non-Hodgkin's lymphoma: Higher concentrations in angioimmunoblastic T-cell lymphoma.
- Published in:
- American Journal of Hematology, 1998, v. 58, n. 4, p. 334, doi. 10.1002/(SICI)1096-8652(199808)58:4<334::AID-AJH15>3.0.CO;2-7
- By:
- Publication type:
- Article
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in Japanese patients with non-Hodgkin lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Discordance in the morphologic diagnosis of lymphocytes in HTLV‐1‐infected individuals.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 3, p. 370, doi. 10.1007/s12185-020-03024-3
- By:
- Publication type:
- Article
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 2, p. 219, doi. 10.1007/s12185-020-03013-6
- By:
- Publication type:
- Article
Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 629, doi. 10.1111/bjh.17895
- By:
- Publication type:
- Article
Follow‐up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: impact on allogeneic haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 479, doi. 10.1111/bjh.15123
- By:
- Publication type:
- Article
Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 356, doi. 10.1111/bjh.13302
- By:
- Publication type:
- Article
Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?
- Published in:
- 2014
- By:
- Publication type:
- journal article
A case of BIA-ALCL in which postoperative chest wall recurrence was highly suspected: the third reported case of BIA-ALCL in Japan.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Factors associated with effects of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Factors associated with effects of Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era.
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 4, p. 386, doi. 10.1007/s12185-014-1636-5
- By:
- Publication type:
- Article
Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma.
- Published in:
- International Journal of Hematology, 2013, v. 98, n. 3, p. 337, doi. 10.1007/s12185-013-1402-0
- By:
- Publication type:
- Article
Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Individual dose adjustment of oral busulfan using a test dose in hematopoietic stem cell transplantation.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
- Published in:
- 2004
- By:
- Publication type:
- journal article
The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin.
- Published in:
- 2002
- By:
- Publication type:
- journal article
A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1149, doi. 10.1007/s00277-023-05157-x
- By:
- Publication type:
- Article
Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients.
- Published in:
- EJHaem, 2020, v. 1, n. 2, p. 507, doi. 10.1002/jha2.111
- By:
- Publication type:
- Article
Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07164-w
- By:
- Publication type:
- Article
Oral histone deacetylase inhibitor tucidinostat (HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2778, doi. 10.1111/cas.15431
- By:
- Publication type:
- Article
Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy.
- Published in:
- Cancer Science, 2021, v. 112, n. 5, p. 1943, doi. 10.1111/cas.14846
- By:
- Publication type:
- Article
Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial.
- Published in:
- Cancer Science, 2020, v. 111, n. 12, p. 4540, doi. 10.1111/cas.14671
- By:
- Publication type:
- Article
Early disease progression in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy.
- Published in:
- Cancer Science, 2018, v. 109, n. 6, p. 2056, doi. 10.1111/cas.13597
- By:
- Publication type:
- Article
Clinical significance of tryptophan catabolism in Hodgkin lymphoma.
- Published in:
- Cancer Science, 2018, v. 109, n. 1, p. 74, doi. 10.1111/cas.13432
- By:
- Publication type:
- Article
Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.
- Published in:
- Cancer Science, 2017, v. 108, n. 5, p. 1007, doi. 10.1111/cas.13230
- By:
- Publication type:
- Article
Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1785, doi. 10.1111/cas.13076
- By:
- Publication type:
- Article
Recent advances in the treatment of adult T-cell leukemia-lymphomas.
- Published in:
- Cancer Science, 2015, v. 106, n. 4, p. 344, doi. 10.1111/cas.12617
- By:
- Publication type:
- Article
Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
- Published in:
- Cancer Science, 2010, v. 101, n. 9, p. 2059, doi. 10.1111/j.1349-7006.2010.01635.x
- By:
- Publication type:
- Article
Consolidation with <sup>90</sup>Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 51, doi. 10.1002/hon.2809
- By:
- Publication type:
- Article
Clinical significance of tryptophan catabolism in follicular lymphoma.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 742, doi. 10.1002/hon.2804
- By:
- Publication type:
- Article